Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Canadian Stocks Climb 0.1%

Canadian Stocks Climb 0.1%

Dow JonesDow Jones2026/08/27 20:31

This article was automatically generated by Dow Jones using technology from Automated Insights.

Stocks in Canada rose Thursday, as the S&P/TSX Composite Index gained 0.1% to 36834.25.

Among large local companies, BlackBerry was the biggest leader during the session, surging 11%, and Obsidian Energy jumped 6.6%. Osisko Metals rounded out the top three movers, as shares jumped 6.5%.

EQB was the biggest laggard, plunging 6.6%, followed by shares of Cronos Group, which tumbled 5.1%. Shares of Groupe Dynamite dropped 3.6%.

Stock indexes in the U.S. rose as the Nasdaq Composite Index increased 1.6%. Meanwhile, the S&P 500 Index gained 0.7%, and the Dow Jones Industrial Average gained 0.2%.

On the currency front, the WSJ Dollar Index held steady at 95.53. The Canadian dollar strengthened 0.2% against the U.S. dollar to US$0.72.

In the bond markets, the 10-year Canadian government bond yield increased 4.78 basis points to 3.702%.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 27, 2026 16:31 ET (20:31 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11